Ibentatug Biosimilar - Research Grade

Human

CSP1ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P53805

Blue ice

The circumsporozoite protein (CSP), the dominant surface antigen of Plasmodium sporozoites, is a leading target for malaria vaccine and antibody research. Our research-grade anti-CSP recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of ibentatug, developed strictly for research use only (RUO). Manufactured to exacting in vivo standards, this ultra-pure, low-endotoxin formulation is supplied in scalable milligram (mg) to gram (g) quantities to serve high-throughput, heavy-usage laboratories. It supports sporozoite-binding and neutralization assays, antigen characterization, in vitro screening, control reagent applications, and in vivo malaria challenge models.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks